|
ISIN No
|
INE947Q01028
|
BSE Code / NSE Code
|
540222 / LAURUSLABS
|
Book Value (Rs.)
|
104.79
|
Face Value
|
2.00
|
|
Bookclosure
|
08/05/2026
|
52Week High
|
2055
|
EPS
|
16.45
|
P/E
|
120.61
|
|
Market Cap.
|
107197.94 Cr.
|
52Week Low
|
843
|
P/BV / Div Yield (%)
|
18.93 / 0.10
|
Market Lot
|
1.00
|
|
Security Type
|
Other
|
|
You can view the investment break up of the company with details such as Security name, Security type, Company type, investmement cost etc.
| YearEnd | Security Name | Security Type | Company Type | Cost of Investments |
| 2603 |
Laurus Bio Pvt. Ltd.
| Equity Share | Subsidiary | 332.04 |
| 2603 |
KRKA Pharma Pvt. Ltd.
| Equity Share | Joint Venture | 154.35 |
| 2603 |
Immunoadoptive Cell Therapy Pvt. Ltd.
| Preference Share | Associate | 116.82 |
| 2603 |
Laurus Synthesis Pvt. Ltd.
| Equity Share | Subsidiary | 99.23 |
| 2603 |
Laurus Bio Pvt. Ltd.
| Preference Share | Subsidiary | 75.00 |
| 2603 |
Laurus Generics Inc
| Equity Share | Subsidiary | 34.16 |
| 2603 |
Sriam Labs Pvt.Ltd.
| Equity Share | Subsidiary | 28.19 |
| 2603 |
Aarvik Therapeutics Inc
| Preference Share | Company | 17.65 |
|